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Underlying Pathophysiology 
Deep Venous Thrombosis in Surgical Orthopedic Patients 
Kelly Marsh, RN 
Introduction to DVT References Continued 
• The term venous thromboembolism (VTE) is defined as a syndrome that collectively 
comprises both deep vein thrombosis (DVT) and pulmonary embolism (PE). Each year 
approximately 350,000-900,000 people in the United States develop VTE and approximately 
100,000 people die according to this cause (Streiff et al., 2014). Unfortunately, the 
reoccurrence rate for VTE remains very high, with an estimated risk of 10%-30% of VTE 
patients will develop another VTE within five years of the first incident (Streiff et al., 2014). 
• Deep vein thrombosis (DVT) is blood clot that forms in a large vein, usually in areas of 
slow blood flow such as the leg or pelvis. Clots can form in the deep veins (DVT) or superficial 
veins (called superficial thrombophlebitis or phlebitis). Superficial blood clots rarely cause 
serious problems. 
• A blood clot can detach or embolize, becoming mobile in the bloodstream. This 
embolism can travel to other places most lethally the heart (resulting in a myocardial 
infarction), the brain (resulting in a stroke) or the lungs (causing a pulmonary embolism). 
• A DVT however, does NOT cause heart attack or stroke. Due to the anatomy of blood 
flow throughout the body, a DVT can only cause a PE. A blood clot in the artery, termed an 
arterial thrombosis, can embolize to cause a heart attack or stroke (Centers for Disease 
Control and Prevention [CDC], 2014). 
• DVT causes significant morbidity and mortality. The most common complication 
associated with DVT is post-thrombotic syndrome (PTS) which occurs in approximately one-
third of patients that experience DVT (Bonner & Johnson, 2013). PTS can cause symptoms of 
chronic pain, heaviness, and swelling to the affected extremity that can result in development 
of venous leg ulcers in severe cases (Bonner & Johnson, 2014). PTS can significantly affect a 
person quality of life and lead to serious disability. 
• While other risk factors exist, the incidence rate of DVT is known to increase in 
association with surgical procedures particularly orthopedic surgery. Without prophylaxis, the 
incidence rate of documented DVT in the orthopedic surgical patients is reported to range 
from 50%-60% (Snyder, 2008). As part of ongoing efforts to increase the efficiency and overall 
cost-effectiveness of hospital operations, the Centers for Medicare and Medicaid Services 
(CMS) and the Joint Commission adopted standardized performance measures for hospitals. 
Among other performance measures, VTE related total hip replacement and total knee 
replacement surgeries were added to the “never event” list defined by CMS as “preventable 
medical errors that result in serious consequences for the patient” (Baser, Supina, Sengupta, 
Wang, & Kwong, 2010).CMS no longer reimburses hospitals for VTE associated with total hip 
and knee replacement surgeries” (Baser, Supina, Sengupta, Wang, & Kwong, 2010). 
• Although guidelines exist for the prevention and management of DVT, their 
implementation remains problematic and VTE incident rates within the United States remains 
high. Several prospective analyses have shown that VTE guidelines are not being routinely 
followed and this gap between guidelines and actual medical practice can partly be explained 
by physician knowledge, attitudes or beliefs (Baser, Supina, Sengupta, Wang, & Kwong, 2010). 
• Research within this topic was performed in anticipation to gain a deeper understanding 
of DVT along with the implications for nursing care. Inquiry and discussion within this area 
serves to bring to light the importance of researching the most current and relevant 
evidenced based practice guidelines regarding DVT risk assessment, signs and symptoms, 
pathophysiology and the significance of DVT pathophysiology in orthopedic patients.  
  
       The classic DVT signs and symptoms 
include calf or thigh pain, unilateral extremity 
edema or enlargement, and calf tenderness 
with foot dorsiflexion (Homans sign), although 
this is neither sensitive nor specific (Meguid, 
2011). The pain may be described as varying 
from a dull ache to sharp pain (Meguid, 2011). 
The pain is most likely attributable to 
pressure on adjacent nerves and due to the 
inflammatory process initiated by the 
coagulation cascade (Meguid, 2011). 
       Increased venous pressure can cause 
symptoms of tachycardia, low grade fever, 
increased skin turgor, and distention of the 
superficial venous collaterals (Meguid, 2011). 
Approximately one-third of DVT cases occur in 
the proximal leg beginning at the femoral vein 
and progressing proximally to the iliac vein 
(Meguid, 2011). With a DVT in this location, 
causing occlusion of the femoral and iliac 
veins; the skin will become cyanotic or pale as 
a result of severe venous obstruction, cool to 
the touch with massive swelling and 
restriction of arterial blood flow (Meguid, 
2011).   
 
 Otterbein University, Westerville, Ohio  
The patient is a 60 year old female in an 
inpatient rehab facility for intensive 
physical therapy following a right total knee 
replacement that was performed one week 
ago. She complains of right lower extremity 
pain that is worse upon ambulation. The 
patient denies any chest pain or shortness 
of breath. Vitals are stable, she is afebrile. 
The patient has a past medical history of 
hypertension, congestive heart failure 
(CHF), obesity and smoking. Upon physical 
examination the patient’s right calf is noted 
to be erythematous and swollen twice the 
size of the unaffected extremity. 2+ pitting 
edema is noted to the right lower extremity 
(RLE) extending into the patients thigh.  
Presentation of Case 
       The patient does not report increased 
pain upon dorsiflexion of the right foot 
indicating a negative Homans sign. A right 
pedal pulse is palpable but slightly weak (2+). 
Localized tenderness is noted to the right calf 
experienced upon light palpation. The total 
knee replacement incision is healing, well 
approximated, staples intact without any 
drainage, redness or other signs or symptoms 
of infection noted. Given this patient’s recent 
surgical procedure, history of CHF and with 
the presented signs and symptoms, a DVT to 
the RLE is highly suspected. A RLE venous 
ultrasonography is ordered. 
      In 1856, Rudolf Virchow postulated that hypercoagulability of blood, stasis of blood, 
and intimal vessel wall injury are casually related to thrombus formation (Meetoo, 2010). 
This postulation still stands today and is now referred to as Virchow’s triad. The 
hemostatic system is faced with the complex task of not only maintaining adequate blood 
circulation to sustain life but also must simultaneously be able to convert blood to an 
insoluble gel to assist in repair at site of vascular injury (Meetoo, 2010). Thus, direct 
damage from a multitude of causes is one of the extrinsic factors that causes a trigger of 
the clotting cascade leading to the possible development of a DVT. 
       Hypercoagulability, or thrombophilia, is condition which directly places an individual 
at risk for a blood clot and is associated with a number of primary (hereditary) and 
secondary (acquired) causes (McCannce, Huether, Brashers & Rote, 2014, p. 1048). 
Primary causes are attributable to defects in proteins involved in hemostasis and 
secondary causes include a variety of clinical disorders or conditions (McCannce, Huether, 
Brashers & Rote, 2014, p. 1048). Some disorders associated with a high risk for venous 
thrombosis or thromboembolism include orthopedic surgery, malignancy, congestive 
heart failure, varicose veins, estrogens and sepsis (McCannce, Huether, Brashers & Rote, 
2014, p. 1048). On the contrary, some disorders associated with a high risk for arterial 
thrombosis or thromboembolism include diabetes mellitus, atherosclerosis, smoking, 
hypertension and polycythemia (McCannce, Huether, Brashers & Rote, 2014, p. 1048). 
       Abnormal clots that adhere to the vessel wall are known as thrombi and are 
composed of blood cells, platelets and fibrin. Arterial thrombi are mostly composed of 
platelet aggregates and fibrin, while venous thrombi are mainly composed of red blood 
cells (Snyder, 2008). The difference in the clot composition is attributed to the difference 
in blood flow conditions in which the clot is formed. Arterial thrombi form under 
conditions of high blood flow and are mainly composed of platelet aggregates and fibrin 
(Snyder, 2008). In sites of turbulent blood flow in the arteries the multitude of platelets 
and endothelial cells may be elevated leading to thrombosis (McCannce, Huether, 
Brashers & Rote, 2014, p. 1048). In venous blood flow, condition of low flow cause venous 
stasis which allows platelets to stay in contact with the endothelium for prolonged times 
and clotting factors that are normally diluted with an increase in blood flow are not 
diluted which as a result contribute to clot formation (McCannce, Huether, Brashers & 
Rote, 2014, p. 1048).  
       If a thrombus detaches from the endothelial wall it becomes an embolus. This mobile 
clot travels through the circulation until it lodges in a blood vessel, blocking blood flow 
and depriving associated tissues or organs of oxygen and nutrition. A major sequelae 
occurring in 20% of DVT patients is the development of a pulmonary embolism (PE) 
caused by the dislodgment of the thrombus (Meguid, 2011). PE’s have a high potential to 
become a fatal event, with ten percent of fatalities occurring within only the first hour 
from the onset of symptoms (Meguid, 2011).  
While it is highly important to assess for DVT in 
susceptible patients, up to 50% of patients will have 
no associated clinical findings in the extremities of 
venographically proven DVT (Mequid, 2011).  
Significance of Pathophysiology  
     DVT is associated with significant morbidity and mortality and therefore imposes a 
considerable economic burden within the United States (LaMori, Shoheiber, Mody, & 
Bookhart, 2014). The pathogenesis associated with DVT plays a critical role in the 
increased risk of development following total hip or knee replacement surgeries. During 
orthopedic surgeries, substantial trauma to the soft tissues or bone is inevitable and it is 
this injury that plays a key role in the activation of the coagulation cascade (Fisher, 
2011). Mechanical destruction of the bone marrow during surgery can also release 
marrow cells and bone fragments into circulation (Fisher, 2011). Cessation or a decrease 
of blood flow not only occurs with manipulation of the limb during surgery, but there is 
also evidence of decreased blood flow following surgery (Fisher, 2011). Venous blood 
flow is temporarily reduced for up to 6 days following a total knee replacement and for 
up to 6 weeks following a total hip replacement (Fisher, 2011). In addition, postoperative 
immobilization and swelling after surgery further contribute to reduced venous return 
and thus an increased risk of DVT.  
Conclusion 
     It is now becoming increasingly recognized that VTE can have a far-reaching impact on 
patients, physicians, and other health care providers including hospitals and nursing 
facilities. VTE is a common complication following orthopedic surgery. An understanding 
of the signs and symptoms of DVT along with the underlying pathophysiology provide 
health care employees the necessary knowledge needed to recognize this preventable 
health care problem. Prevention of DVT in this patient population requires a multimodal 
approach with emphasis upon DVT prophylaxis as a standard of care for all patient 
undergoing total hip or knee replacements. Although guidelines for the prevention and 
treatment of DVT exist, their implementation remains problematic in hospitals across the 
United States (Baser, Supina, Sengupta, Wang, & Kwong, 2010). Currently, hospital stays 
for DVT and PE represent a substantial cost burden to the U.S. health care system 
(LaMori, Shoheiber, Mody, & Bookhart, 2014). Direct patient care staff including nurses 
and physicians alike play a key role in the primary prevention of DVT.  
Implications for Nursing Care 
     It remains critical that all patient care staff understand that patients undergoing 
orthopedic surgeries are at a high risk for DVT or PE and be vigilant in assessing for DVT. 
Assuring that these patients are placed on DVT prophylactic medication as prescribed by 
the physician is crucial in DVT prevention. “Health care systems have the potential to 
reduce the clinical and economic burden of VTE by ensuring that evidenced-based, 
guideline recommended anticoagulation therapy is adhered to by patients with an initial 
VTE” (LaMori, Shoheiber, Mody, & Bookhart, 2014). There are numerous measures that 
nursing staff can utilize to prevent DVT in this extremely high risk group. Prevention of 
venous stasis can include interventions that encourage early ambulation or the application 
of compression hose or intermittent pneumatic compression boots. Hydration 
maintenance by encouraging oral liquids or assessment for the need of I.V. fluid therapy 
will assist in decreasing states that may lead to hypercoagulability. Patient education is of 
utmost importance for the prevention and early recognition of DVT. 
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